• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter to the Editor: Epidemiological Comments on the Effectiveness of the Varicella Vaccine in Korea.

作者信息

Choi BongKyoo, Shin Ji Hyeun, Lee Jee Eun, Koh Sangbaek

机构信息

Department of Research and Early Development, GC Pharma, Yongin, Korea.

Department of Medicine, University of California, Irvine, CA, USA.

出版信息

J Korean Med Sci. 2020 Jul 20;35(28):e265. doi: 10.3346/jkms.2020.35.e265.

DOI:10.3346/jkms.2020.35.e265
PMID:32686377
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7371459/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d776/7371459/39d97691fe8d/jkms-35-e265-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d776/7371459/39d97691fe8d/jkms-35-e265-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d776/7371459/39d97691fe8d/jkms-35-e265-g001.jpg

相似文献

1
Letter to the Editor: Epidemiological Comments on the Effectiveness of the Varicella Vaccine in Korea.致编辑的信：关于韩国水痘疫苗有效性的流行病学评论
J Korean Med Sci. 2020 Jul 20;35(28):e265. doi: 10.3346/jkms.2020.35.e265.
2
Effects of One-dose Varicella Vaccination on Disease Severity in Children during Outbreaks in Seoul, Korea.韩国首尔暴发疫情期间一剂水痘疫苗接种对儿童疾病严重程度的影响。
J Korean Med Sci. 2019 Mar 7;34(10):e83. doi: 10.3346/jkms.2019.34.e83. eCollection 2019 Mar 18.
3
The Author's Response: Effects of One-dose Varicella Vaccination on Disease Severity in Children during Outbreaks in Seoul, Korea.
J Korean Med Sci. 2020 Jul 20;35(28):e266. doi: 10.3346/jkms.2020.35.e266.
4
Effectiveness of Varicella Vaccination Program in Preventing Laboratory-Confirmed Cases in Children in Seoul, Korea.韩国首尔水痘疫苗接种计划在预防儿童实验室确诊病例方面的有效性。
J Korean Med Sci. 2016 Dec;31(12):1897-1901. doi: 10.3346/jkms.2016.31.12.1897.
5
Letter to the Editor: Effectiveness of the Varicella Vaccine in Korea: Unresolved Issues.致编辑的信：韩国水痘疫苗的有效性：未解决的问题。
J Korean Med Sci. 2021 Jul 12;36(27):e200. doi: 10.3346/jkms.2021.36.e200.
6
Letter to the Editor: Effectiveness of the Varicella Vaccine Among Korean Children: Suggestions for Future Research.致编辑的信：水痘疫苗在韩国儿童中的有效性：对未来研究的建议。
J Korean Med Sci. 2022 Jan 3;37(1):e17. doi: 10.3346/jkms.2022.37.e17.
7
Varicella outbreaks after vaccine licensure: should they make you chicken?疫苗获批后水痘爆发：它们会让你害怕吗？
Pediatrics. 1999 Sep;104(3 Pt 1):561-3. doi: 10.1542/peds.104.3.561.
8
Vaccination history in elementary school children enrolled in the varicella epidemic investigations held in Jeju-si, Korea in the first half of 2017.2017年上半年在韩国济州岛进行的水痘疫情调查中登记的小学生的疫苗接种史。
Epidemiol Health. 2017 Nov 13;39:e2017053. doi: 10.4178/epih.e2017053. eCollection 2017.
9
Varicella and varicella vaccination in South Korea.韩国的水痘与水痘疫苗接种
Clin Vaccine Immunol. 2014 May;21(5):762-8. doi: 10.1128/CVI.00645-13. Epub 2014 Mar 26.
10
Vaccine effectiveness and severity of varicella among previously vaccinated children during outbreaks in day-care centers with low vaccination coverage.在疫苗接种覆盖率低的日托中心爆发水痘期间，既往接种疫苗儿童的疫苗效力及水痘严重程度。
Pediatr Infect Dis J. 2005 Mar;24(3):233-6. doi: 10.1097/01.inf.0000154323.20387.82.

引用本文的文献

1
Seroprevalence comparison of different varicella vaccines among Turkish children.土耳其儿童中不同水痘疫苗的血清流行率比较
Hum Vaccin Immunother. 2022 Nov 30;18(5):2067443. doi: 10.1080/21645515.2022.2067443. Epub 2022 Apr 21.
2
Letter to the Editor: Effectiveness of the Varicella Vaccine Among Korean Children: Suggestions for Future Research.致编辑的信：水痘疫苗在韩国儿童中的有效性：对未来研究的建议。
J Korean Med Sci. 2022 Jan 3;37(1):e17. doi: 10.3346/jkms.2022.37.e17.
3
Letter to the Editor: Effectiveness of the Varicella Vaccine in Korea: Unresolved Issues.

本文引用的文献

1
Increasing varicella incidence rates among children in the Republic of Korea: an age-period-cohort analysis.韩国儿童水痘发病率上升：一项年龄-时期-队列分析。
Epidemiol Infect. 2019 Jan;147:e245. doi: 10.1017/S0950268819001389.
2
Trends in varicella and herpes zoster epidemiology before and after the implementation of universal one-dose varicella vaccination over one decade in South Korea, 2003-2015.韩国实施十余年水痘单剂疫苗普遍接种前后（2003-2015 年）水痘和带状疱疹流行病学趋势。
Hum Vaccin Immunother. 2019;15(11):2554-2560. doi: 10.1080/21645515.2019.1603985. Epub 2019 May 7.
3
Protection against Severe Varicella Disease.
致编辑的信：韩国水痘疫苗的有效性：未解决的问题。
J Korean Med Sci. 2021 Jul 12;36(27):e200. doi: 10.3346/jkms.2021.36.e200.
预防严重水痘疾病。
J Korean Med Sci. 2019 Mar 12;34(10):e93. doi: 10.3346/jkms.2019.34.e93. eCollection 2019 Mar 18.
4
Effects of One-dose Varicella Vaccination on Disease Severity in Children during Outbreaks in Seoul, Korea.韩国首尔暴发疫情期间一剂水痘疫苗接种对儿童疾病严重程度的影响。
J Korean Med Sci. 2019 Mar 7;34(10):e83. doi: 10.3346/jkms.2019.34.e83. eCollection 2019 Mar 18.
5
Epidemiological Impact of the Korean National Immunization Program on Varicella Incidence.韩国国家免疫计划对水痘发病率的流行病学影响。
J Korean Med Sci. 2019 Feb 7;34(7):e53. doi: 10.3346/jkms.2019.34.e53. eCollection 2019 Feb 25.
6
Varicella vaccination - the global experience.水痘疫苗——全球经验
Expert Rev Vaccines. 2017 Aug;16(8):833-843. doi: 10.1080/14760584.2017.1343669. Epub 2017 Jul 13.
7
Effectiveness of Varicella Vaccination Program in Preventing Laboratory-Confirmed Cases in Children in Seoul, Korea.韩国首尔水痘疫苗接种计划在预防儿童实验室确诊病例方面的有效性。
J Korean Med Sci. 2016 Dec;31(12):1897-1901. doi: 10.3346/jkms.2016.31.12.1897.
8
National Infectious Diseases Surveillance data of South Korea.韩国国家传染病监测数据。
Epidemiol Health. 2014 Nov 11;36:e2014030. doi: 10.4178/epih/e2014030. eCollection 2014.
9
Varicella and varicella vaccination in South Korea.韩国的水痘与水痘疫苗接种
Clin Vaccine Immunol. 2014 May;21(5):762-8. doi: 10.1128/CVI.00645-13. Epub 2014 Mar 26.
10
Comparative estimation of coverage between national immunization program vaccines and non-NIP vaccines in Korea.韩国国家免疫规划疫苗和非国家免疫规划疫苗覆盖情况的比较评估。
J Korean Med Sci. 2013 Sep;28(9):1283-8. doi: 10.3346/jkms.2013.28.9.1283. Epub 2013 Aug 28.